GOLDMAN SACHS GROUP INC - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$8,827,142
-18.5%
345,485
-8.5%
0.00%0.0%
Q2 2023$10,833,182
+43.3%
377,726
+19.8%
0.00%0.0%
Q1 2023$7,560,186
+44.5%
315,402
+2.2%
0.00%
+100.0%
Q4 2022$5,232,295
+7.7%
308,508
-5.9%
0.00%0.0%
Q3 2022$4,858,000
-23.0%
327,795
-18.2%
0.00%0.0%
Q2 2022$6,311,000
-17.0%
400,937
+42.2%
0.00%
-50.0%
Q1 2022$7,602,000
-24.8%
281,990
+3.2%
0.00%0.0%
Q4 2021$10,115,000
+50.0%
273,324
+93.7%
0.00%
+100.0%
Q3 2021$6,743,000
+239.0%
141,128
+140.1%
0.00%
Q2 2021$1,989,000
-73.9%
58,781
-68.1%
0.00%
-100.0%
Q1 2021$7,615,000
-64.1%
184,377
-62.3%
0.00%
-60.0%
Q4 2020$21,231,000
+14.8%
489,401
+13.6%
0.01%0.0%
Q3 2020$18,486,000
+396.7%
430,903
+441.2%
0.01%
+400.0%
Q2 2020$3,722,000
+330.8%
79,617
+25.2%
0.00%
Q1 2020$864,000
+591.2%
63,594
+454.6%
0.00%
Q4 2019$125,00011,4660.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders